Back to News
Market Impact: 0.2
Evogene Gets 180-day Nasdaq Extension To Regain Compliance
Source: Nasdaq
Regulation & LegislationCompany Fundamentals
Evogene Ltd. received an additional 180 days from Nasdaq to regain compliance with the exchange's $1 minimum bid-price requirement. The extension averts an immediate delisting risk but highlights continued pressure on EVGN's share price and creates a deadline for the company to restore compliance.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly negative
Sentiment Score
-0.35
Ticker Sentiment
EVGN-0.45
More News
- Meta stock enjoys best month since 2022 on AI momentum
- New report finds that rapid expansion of tokenization is giving rise to new styles of investing
- Why is Moderna stock down 4% today?
- Why is Robinhood Markets stock rallying today?
- Freedom Capital reiterates CoreWeave stock Buy rating at $151 target
- Freedom Broker raises IDT stock price target to $85 on strong results
From AllMind Research
- Anthropic IPO Preview: Valuation, Timing, and What to Watch
- Shein After the IPO: Venue, Valuation, and What Must Be Proved
- What AI Research Tools Should a Small Hedge Fund Buy First?
- AI Software for Buy-Side Teams: Build the Research Stack
- Augmented Intelligence: AllMind, Elevate Human Judgement With an Accessible, Powerful, Data-Driven Financial AI Toolkit